U.S. Cell Viability Assays Market Size & Outlook, 2023-2030
U.S. cell viability assays market, 2018-2030 (US$M)
Related Markets
U.S. cell viability assays market highlights
- The U.S. cell viability assays market generated a revenue of USD 421.7 million in 2023 and is expected to reach USD 818.4 million by 2030.
- The U.S. market is expected to grow at a CAGR of 9.9% from 2024 to 2030.
- In terms of segment, consumables was the largest revenue generating product in 2023.
- Consumables is the most lucrative product segment registering the fastest growth during the forecast period.
Cell viability assays market data book summary
| Market revenue in 2023 | USD 421.7 million |
| Market revenue in 2030 | USD 818.4 million |
| Growth rate | 9.9% (CAGR from 2023 to 2030) |
| Largest segment | Consumables |
| Fastest growing segment | Consumables |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Consumables, Instruments |
| Key market players worldwide | Thermo Fisher Scientific Inc, Agilent Technologies Inc, Bio-Rad Laboratories Inc, Merck KGaA, BD, PerkinElmer, Promega, Abcam PLC, Charles River Laboratories International Inc, Biotium, Creative Bioarray |
Other key industry trends
- In terms of revenue, U.S. accounted for 30.1% of the global cell viability assays market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. cell viability assays market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 153.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cell Viability Assays Market Scope
Cell Viability Assays Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. cell viability assays market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell viability assays market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 65.38% in 2023. Horizon Databook has segmented the U.S. cell viability assays market based on consumables, instruments covering the revenue growth of each sub-segment from 2018 to 2030.
- U.S. Cell Viability Assays Product Outlook (Revenue, USD Million, 2018-2030)
- Consumables
- Microplates
- Reagents and Assay Kits
- Dye exclusion assays
- Colorimetric assays
- Fluorometric assays
- Luminometric assays
- Instruments
- Spectrophotometer
- Microscopy
- Cell imaging and analysis system
- Flow Cytometry
- Others
- Consumables
- U.S. Cell Viability Assays Application Outlook (Revenue, USD Million, 2018-2030)
- Drug Discovery and Development
- Stem Cell Research
- Diagnostics
- U.S. Cell Viability Assays End-user Outlook (Revenue, USD Million, 2018-2030)
- Biopharmaceutical & Pharmaceutical Companies
- CROs & CMOs
- Academic & Research Institutes
- Diagnostic Labs
Reasons to subscribe to U.S. cell viability assays market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. cell viability assays market databook
-
Our clientele includes a mix of cell viability assays market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. cell viability assays market, including forecasts for subscribers. This country databook contains high-level insights into U.S. cell viability assays market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. cell viability assay market report size, by product, 2018-2030 (US$M)
U.S. Cell Viability Assays Market Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
